Federal contract award
80JSC025F7032
HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CMS) TERRESTRIALLY FABRICATED INTO PHYSIOLOGICALLY RELEVANT 3D ENGINEERED HEART TISSUES (EHTS) WILL BE STUDIED ABOARD THE INTERNATIONAL SPACE STATION (ISS).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | National Aeronautics and Space Administration |
| Office | NASA JOHNSON SPACE CENTER |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | AR12 — SPACE R&D SERVICES; SPACE FLIGHT, RESEARCH AND SUPPORTING ACTIVITIES; APPLIED RESEARCH |
| Parent award / vehicle | 80JSC019D0026 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $450.0K |
| Current contract value | $450.0K |
| Potential contract value / ceiling | $450.0K |
| Start date | Jan 29, 2025 |
| Current end date | Feb 20, 2027 |
| Potential end date | Feb 20, 2027 |
| Latest award activity | Jan 26, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 26, 2026 | P00003 | $100.0K | HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CMS) TERRESTRIALLY FABRICATED INTO PHYSIOLOGICALLY RELEVANT 3D ENGINEERED HEART TISSUES (EHTS) WILL BE STUDIED ABOARD THE INTERNATIONAL SPACE STATION (ISS). |
| Sep 8, 2025 | P00002 | $125.0K | HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CMS) TERRESTRIALLY FABRICATED INTO PHYSIOLOGICALLY RELEVANT 3D ENGINEERED HEART TISSUES (EHTS) WILL BE STUDIED ABOARD THE INTERNATIONAL SPACE STATION (ISS). |
| Feb 17, 2025 | P00001 | $0 | HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CMS) TERRESTRIALLY FABRICATED INTO PHYSIOLOGICALLY RELEVANT 3D ENGINEERED HEART TISSUES (EHTS) WILL BE STUDIED ABOARD THE INTERNATIONAL SPACE STATION (ISS). |
| Jan 29, 2025 | 0 | $225.0K | HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CMS) TERRESTRIALLY FABRICATED INTO PHYSIOLOGICALLY RELEVANT 3D ENGINEERED HEART TISSUES (EHTS) WILL BE STUDIED ABOARD THE INTERNATIONAL SPACE STATION (ISS). |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-02-20 (118 days from calculation)
- +35 points
- 14 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2026-01-26
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.